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Mechanical ventilationAbstract Background: Chromogranin A (CgA) as a marker of catecholamines may reﬂect the
physiological stress load during the current critical illness which will affect the course of mechanical
ventilation and the progress of the weaning process. The aim of the work was to assess the serum
chromogranin level (CgA) in mechanically ventilated critically ill septic patients as a predictor of
weaning and its relation to other conventional parameters.
Patients and methods: The present study was carried on 65 adult mechanically ventilated patients
who presented with severe sepsis and septic shock in the intensive care units. The patients were
included in the study after fulﬁlling the criteria of severe sepsis and septic shock. Patients were
categorized consecutively into 2 groups: Group I: included 30 patients who were weaned success-
fully. Group II: included 19 patients who failed weaning. Serum chromogranin A was measured
by commercially available ELISA KIT.
Results: The mean serum chromogranin A was signiﬁcantly higher in the failed group compared
to the success group on admission, after 24 h and after 72 h. The means in the failed group were
1922.21 ± 1800.86 ng/ml, 2240.16 ± 1927.84 ng/ml and 2168.26 ± 1851.16 ng/ml on admission,
after 24 h and after 72 h, respectively while in the success group, they were 224.87 ± 177.9
ng/ml, 234.17 ± 165.81 ng/ml and 256.70 ± 163.81 ng/ml on admission, after 24 h and after
72 h, respectively.
956 T. Zaytoun et al.Conclusion: The serum chromogranin A can be used as a predictor of the weaning in septic
mechanically ventilated patients.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Critical illness is frequently associated with a systemic inﬂam-
matory response syndrome (SIRS), characterized by physio-
logical manifestations of inﬂammation (altered temperature,
leukocytosis or bone marrow suppression, tachycardia and
tachypnea) [1]. This inﬂammatory response is accompanied
by biochemical and immunological evidence of immune system
activation and can be precipitated by both sterile and infective
insults [2]. Although often life-saving, mechanical ventilation
can be associated with life-threatening complications, accord-
ingly, it is essential to safely discontinue mechanical ventilation
at the earliest possible time [3]. Several weaning predictor tests
have been proposed and studied over the years, these tests
include measurements of breathing pattern, pulmonary gas
exchange, muscle strength, and neuromuscular drive, their
goal is to safely speed up the weaning process [3]. Since the
timing of weaning is so crucial, it is necessary to have reliable
information that can help to determine the success of the
weaning trial. Studies have shown the variability of clinical
judgment in this regard, and objective predictors have been
evolved to assist in the decision-making process, often, there
is a delay in contemplating weaning [4]. Reliable predictors
would obviate unwarranted prolongation of mechanical venti-
lation by helping to recognize the weanable patient early [5].
Predictors also have the potential for identifying speciﬁc phys-
iological derangements responsible for weaning failure. At
present, no single predictor, or set of predictors, has the
desired reliability and such a prediction remains a difﬁcult
challenge [6].
The acute response to stress causes the release of catechol-
amines from the chromafﬁn cells of the adrenal medulla
accompanied by numerous proteins, peptides such as chro-
mogranin A (CgA) and its natural fragments [7]. Chromogra-
nin A (CgA) is a 439-amino acid protein with a molecular
weight of 48–60 kDa, depending on glycosylation and phos-
phorylation status. It is a member of the granin family of pro-
teins and polypeptides. Granins are widespread in endocrine,
neuroendocrine, peripheral, and central nervous tissues, where
they are found in secretory granules alongside the tissue-spe-
ciﬁc secretion products. The role of granins within the granules
is to maintain the regulated secretion of these signaling mole-
cules [8].
Granins are valuable indicators of sympathoadrenal activ-
ity and clinically useful markers of secretion from normal
and neoplastic neuroendocrine cells [9]. Chromogranin A is a
standard probe for immunohistochemical analyses of neuroen-
docrine tumors, and elevated serum CgA levels are diagnostic
of these neoplasms [10,11]. Plasma CgA levels are elevated in
patients with kidney, liver, or heart failure. As a result of the
retention of midmolecule fragments, CgA levels in patients
with the end-stage renal disease can be as high as those in
patients with neuroendocrine neoplasia, suggesting that the
kidneys have an important role in eliminating CgA [12].Neuroendocrine activation also occurs in patients with conges-
tive heart failure, and the plasma CgA level rises as a result of
this activation [13]. Chromogranin A (CgA) in plasma is a neu-
roendocrine marker of sympathetic stress, has been shown to
predict mortality in medical intensive care related to the stress
load of the current critical illness [7,9].
Aim of the work
The aim of the present study was to assess the serum chro-
mogranin level (CgA) in mechanically ventilated critically ill
septic patients as a predictor of weaning and its relation to
other conventional parameters (c-reactive protein level(CRP),
acute physiology and chronic health evaluation score
APACHE II and Simpliﬁed acute physiology score SAPS II
scores).
Patients and methods
This study was approved by the King Fahd Hospital-Dam-
mam Ethics and the Institutional Research Board (IRB). All
patients gave their written informed consent before participat-
ing in the study. The present study was carried on 65 adult
mechanically ventilated patients who presented with severe
sepsis and septic shock in the intensive care units in the King
Fahad Hospital-KSA and Menofyia University Hospital.
The patients were included in the study after fulﬁlling the cri-
teria of severe sepsis and septic shock according to the criteria
of the American College of Chest Physicians/society of Critical
Care Medicine [14]. This study was carried out in the period
from January 2012 to June 2013.
Inclusion criteria
Adult mechanically ventilated patients with severe sepsis and
septic shock according to the criteria of the American College
of Chest Physicians/society of Critical Care Medicine were
included [14].
Exclusion criteria
1. History of neuroendocrine tumors.
2. History of pheochromocytoma.
3. Patients with lung, prostate, colon, and breast tumors.
4. Patients with carcinoid tumors.
65 Patients were included in the study, 6 patients were
excluded because they did not stay in the Intensive Care Unit
(ICU) more than 72 h and 10 patients were excluded because
consent cannot be obtained (Fig. 1), patients were categorized
consecutively into 2 groups:
Group I: included 30 patients who were weaned successfully
(the success group).
Chromogranin A as a marker of weaning in ill septic patients 957Group II: included 19 patients who failed weaning (the
failed group).
For each patient enrolled in this study the following was
done on admission to help to deﬁne inclusion or exclusion
of the studied patients and to fulﬁll the elements of acute
physiology and chronic health evaluation (APACHE) II
score:
 Complete history taking from the relatives of the patient
including:
– Demographic data.
– Past medical history.
– Drug history.
 Clinical examination:
– Systolic blood pressure, diastolic blood pressure and the
mean blood pressure (mmHg) will be recorded.
– Heart rate (beat/minute).
– Respiratory rate (cycle/minute).
– Temperature (C).
– Cardiac, chest and abdominal examination.
 Arterial blood gas measurements (ABG).
 Laboratory investigations (routine laboratory work):
– Complete blood picture (CBC).
– Liver function tests: AST (IU/L), ALT (IU/L), total
protein (g/L), and serum albumin (g/L).
– Serum electrolytes: Na (mEq/L), K (mEq/L).
– The following markers were measured on admission,
after 12 h and after 72 h:
– serum creatinine (N creatinine 53–88 mmol/L).
– serum urea (N urea 2.7–7.2 mmol/L).
– serum chromogranin level (N< 93 ng/ml).
The method of plasma chromogranin A (CgA) determination
Blood samples were obtained after overnight fasting and were
collected in tubes containing EDTA. Within 60 min after
collection, the samples were centrifuged at 6000 rpm with an
ALC 4235A Centrifuge, and the plasma was stored at65 patients with severe 
sepsis and septic shock 
were enrolled 
6 patients did 
not stay more 
than 72 hours 
in ICU 
10 patients 
refused to give 
consent
49 mechanically ventilated 
chromogranin was measured on 






Figure 1 Summarizes the selection of patients included.20 C until assay. The CgA plasma level was measured with
a technique previously validated in our laboratory (DAKO
CgA ELISA kit; Dako, Glostrup, Denmark cat. No K0025).
All patients included in the study were managed according
to the sepsis campaign guidelines [14], and Mechanical ventila-
tion according to unit protocol, spontaneous breathing trail
was done daily for every patient.
Outcome variables
1. Success of weaning or not.
2. ICU length of stay (LOS).Statistical analysis
Results are presented as mean ± standard deviation (SD)
unless otherwise stated. Student t-test was used to compare
both studied groups. Pearson coefﬁcient was used to study cor-
relations between different parameters. 5% was chosen as the
level of signiﬁcance for the used statistical tests (<5% consid-
ered signiﬁcant and <1% considered highly signiﬁcant). All
statistical analyses were performed using the Statistical Pack-
age for Social Science (SPSS) software version 16.Results
There were no signiﬁcant differences between both groups as
regards serum albumin, platelet count (on admission, after
24 h and after 72 h), and on admission CRP (Table 1). The
mean serum chromogranin A was signiﬁcantly higher in the
failed group compared to the success group on admission, after
24 h and after 72 h. The means in the failed group were
1922.21 ± 1800.86 ng/ml, 2240.16 ± 1927.84 ng/ml and 2168
.26 ± 1851.16 ng/ml on admission, after 24 h and after 72 h,
respectively while in the success group, they were 224.87 ±
177.9 ng/ml, 234.17 ± 165.81 ng/ml and 256.70 ± 163.81
ng/ml on admission, after 24 h and after 72 h, respectively.
ICU length of stay was signiﬁcantly higher in the failed
group (11.11 ± 4.53 days) compared to the success group
(5.63 ± 1.67) ( p= 0.000). The mean C-reactive protein
(CRP) after 24 h was 167.46 ± 115.52 in the failed group and
139.73 ± 131.83 in the success group. It was signiﬁcantly higher
in the failed group compared to the success group. ( p= 0.010).
Also, after 72 h, it was signiﬁcantly higher in the failed group
(165.05 ± 104.07 mg/L) compared to the success group
(89.61 ± 78.36 mg/L). APACHE score was signiﬁcantly higher
in the failed group (32.37 ± 13.21) compared to the success
group (17.97 ± 10.09), ( p= 0.000). The mean SAPS (Simpli-
ﬁed Acute Physiology Score) was 60.37 ± 29.79 in the failed
group and 36.53 ± 19.71 in the success group. It was signiﬁ-
cantly higher in the failed group compared to the success group
(p= 0.001). Themean agewas 63.26 ± 14.08 years in the failed
group and 49.47 ± 19.35 years in the success group. It was sig-
niﬁcantly higher in the failed group compared to the success
group (p= 0.010). The serum lactate level was signiﬁcantly
higher in the failed group (4.52 ± 4.01 mmol/L) compared to
the success group (2.38 ± 1.84 mmol/L) (p= 0.026). Serum
urea was signiﬁcantly higher in the failed group
(19.86 ± 17.17 mmol/L) compared to the success group
(7.47 ± 7.06 mmol/L) (p= 0.022).
Table 1 Comparison between successful and failed weaning groups.
Weaning No Mean SD t P
Age Failed 19 63.26 14.08 2.686 0.010*
Success 30 49.47 19.35
Serum lactate (mmol/L) Failed 19 4.52 4.01 2.292 0.026*
Success 30 2.38 1.84
Serum albumin (g/L) Failed 19 22.95 4.6 0.043 0.966
Success 30 22.87 7.27
Serum urea (mmol/L) Failed 19 19.86 17.14 2.366 0.022*
Success 30 7.47 7.06
Serum creatinine (mmol/L) Failed 19 232.37 205.75 3.147 0.003*
Success 30 99.4 85.9
Platelet count 0 h (·103/cc) Failed 19 206.68 166.67 1.117 0.27
Success 30 272 217.36
Platelet count 24 h (·103/cc) Failed 19 220.63 178 0.723 0.473
Success 30 259.5 186.74
Platelet count 72 h (·103/cc) Failed 19 223.58 190.6 0.148 0.883
Success 30 230.8 148.43
C-RP 0 h (mg/L) Failed 19 167.46 115.52 0.752 0.456
Success 30 139.73 131.83
C-RP 24 h (mg/L) Failed 19 178.33 121.11 2.47 0.017*
Success 30 105.87 84.38
C-RP 72 h (mg/L) Failed 19 165.05 104.07 2.888 0.006*
Success 30 89.61 78.36
APACHE II Failed 19 32.37 13.21 4.313 0.000*
Success 30 17.97 10.09
SAPS Failed 19 60.37 29.79 3.376 0.001*
Success 30 36.53 19.71
Serum Cg A 0 h (ng/ml) Failed 19 1922.21 1800.86 5.154 0.000*
Success 30 224.87 177.9
Serum Cg A 24 h (ng/ml) Failed 19 2240.16 1927.84 5.701 0.000*
Success 30 234.17 165.81
Serum Cg A 72 h (ng/ml) Failed 19 2168.26 1851.16 5.6 0.000*
Success 30 256.7 163.81
ICU length of stay (days) Failed 19 11.11 4.53 6.026 0.000*
Success 30 5.63 1.67
APACHE II (acute physiology and chronic health evaluation II). SAPS (simpliﬁed acute physiology score). C-RP (C-reactive protein). CgA
(chromogranin A).
958 T. Zaytoun et al.Table 2 shows that in the failed group, there was no signif-
icant correlation between on admission serum chromogranin
A and the other parameters. After 24 h, there was signiﬁcant
direct correlation between chromogranin and serum lactate,
while there was no signiﬁcant correlation with the other
parameters. After 72 h, there was signiﬁcant direct correlation
between chromogranin and serum creatinine, while there was
no signiﬁcant correlation with the other parameters.
There was no signiﬁcant correlation between serum chro-
mogranin A and the other parameters on admission, after
24 h and after 72 h.
Table 3 shows that the multivariate analysis of predictors of
success of weaning revealed that the CgA level at 24 h was the
ﬁrst predictor of success of weaning with R= 20.03 and
p= 0.000 and this was followed by the CgA level at 72 h with
R= 19.61 and p= 0.000 then the CgA level on admission
with R= 17.69 and p= 0.000.
Discussion
Liberation from mechanical ventilation is a central component
in the care of the critically ill patient. Weaning is the progres-
sive reduction in the amount of ventilatory support delivered
by a mechanical ventilator [15].In the present study, the two groups were not matched as
regards the age, as the mean age was 63.26 ± 14.08 years in
the failed group and in the success group it was
49.47 ± 19.35 years, the age (p= 0.010), and success of wean-
ing were associated with the younger age group, this ﬁnding
agreed with ﬁnding by Hudson et al. [16] where the difference
in age which is a patient-speciﬁc factor was found to modulate
the probability of occurrence of acute respiratory distress syn-
drome (ARDS).
The serum albumin level in the current work did not
differ signiﬁcantly between both groups of the study, this
ﬁnding was opposite to the previous concept of the associa-
tion between Low serum albumin levels and poor outcome
as found by Gong et al. [17] in their prospective study in
688 patients with sepsis, trauma, aspiration and hypertrans-
fusion which demonstrated increased odds of developing
(ARDS) in patients with serum albumin <2.3 g/dl (OR,
1.80; CI, 1.18–2.73) (p= 0.01) and also opposite to the
retrospective analysis done by Mangialardi et al. [18] that
included 455 ICU patients in a sepsis trial, 178 of whom
developed ARDS, showed that reduced initial total serum
protein levels and protein change over time were the most
signiﬁcant predictors of ARDS development and prolonged
mechanical ventilation.
Table 2 Correlation between chromogranin and the other parameters in failed and successful weaning groups.
Cg A 0 h Cg A 24 h Cg A 72 h
Failed Success Failed Success Failed Success
Age r 0.317 0.19 0.058 0.211 0.108 0.166
P 0.186 0.315 0.815 0.263 0.66 0.381
Serum lactate (mmol/L) r 0.116 0.04 0.562 0.02 0.173 0.003
P 0.636 0.832 0.012* 0.915 0.48 0.988
Serum albumin (g/L) r 0.026 0.049 0.146 0.008 0.131 0.232
p 0.914 0.796 0.551 0.966 0.592 0.218
Serum urea (mmol/L) r 0.16 0.161 0.214 0.126 0.218 0.114
p 0.513 0.395 0.38 0.505 0.37 0.55
Serum creatinine (mmol/L) r 0.271 0.238 0.226 0.23 0.468 0.173
p 0.262 0.205 0.352 0.222 0.043* 0.361
Platelet count (·103/cc) r 0.211 0.111 0.389 0.065 0.245 0.165
p 0.387 0.559 0.1 0.733 0.312 0.385
C-RP (mg/L) r 0.449 0.237 0.142 0.053 0.007 0.095
P 0.054 0.207 0.561 0.781 0.979 0.616
APACHE II r 0.138 0.202 0.388 0.134 0.449 0.082
p 0.572 0.284 0.1 0.48 0.054 0.666
SAPS r 0.032 0.253 0.266 0.147 0.441 0.084
P 0.898 0.178 0.272 0.439 0.059 0.657
Cg A (chromogranin A). APACHE II (acute physiology and chronic health evaluation II). SAPS (simpliﬁed acute physiology score). C-RP
(C-reactive protein).
Table 3 Multivariate analysis of predictors of success of
weaning in critically ill septic patient groups.
R P
Age 6.52 0.011*
Serum lactate 4.926 0.027*
Serum albumin 0.002 0.965
Serum urea 5.216 0.022*
Serum creatinine 8.528 0.004*
Platelet count 0 h 1.267 0.266
Platelet count 24 h 0.539 0.463
Platelet count 72 h 0.023 0.88
C-reactive protein 0 h 0.582 0.446
C-reactive protein 24 h 5.629 0.018*
C-reactive protein 72 h 7.386 0.007
Chromogranin A 0 h 17.69 0.000*
Chromogranin A 24 h 20.03 0.000*
Chromogranin A 72 h 19.61 0.000*
APACHE II 13.9 0.000*
SAPS 9.565 0.002*
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both studied groups could be attributed to the presence
of low serum albumin level in most of the patients in both
groups.
Regarding the serum lactate level, it was higher in the failed
group with a mean of 4.52 ± 4.01 mmol/L compared to
2.38 ± 1.84 mmol/L in the success group, respectively, and
this difference was statistically signiﬁcant (p= 0.026). Plasma
lactate levels are commonly elevated in the critically ill patients
due to increased lactate production and less frequently to
reduced lactate clearance [19,20]. Plasma lactate levels on
admission and the trend in lactate levels may both be used
as a marker of illness severity and prognosis in the critically
ill patient [21,22]. This ﬁnding could be explained by the nature
of the weaning process itself and its strong association with
increased patient stress, also the muscle burden of therespiratory muscles, all contribute to increased lactate level
as a marker of metabolic stress and increased severity of illness
in the failed group.
As regards the c-reactive protein (CRP) level, it showed no
statistically signiﬁcant difference between the two studied
groups on admission, but this ﬁnding changed after 24 h and
72 h where the CRP level was signiﬁcantly higher in the failed
group with a mean of 178.33 ± 121.11 mg/L after 24 h and
mean of 165.05 ± 104.07 mg/L after 72 h in comparison to
mean of 105.87 ± 84.38 mg/L after 24 h and mean of
89.61 ± 78.36 mg/L after 72 h in the success group, respec-
tively (p= 0.017) (p= 0.006).
C-reactive protein is a biomarker in common clinical use to
delineate the activity of a host of inﬂammatory conditions such
as sepsis, cardiovascular disease and rheumatological disorders
[23].
The CRP results were contradictory to many other studies
which reported that patients with respiratory distress and ele-
vated levels of CRP show better prognosis compared to
patients with ARDS and lower CRP values as found by Kew
et al. [24]. Also in keeping with this ﬁnding, there was an
inverse association between increasing CRP level and 28-day
mortality and requirement for mechanical ventilation as found
by Bajwa et al. [25] in a study done on 177 patients with ARDS
where 60-day mortality and days of mechanical ventilation
were lower among patients with higher CRP levels.
In contradiction to Bajwa et al. [25] ﬁndings, length of ICU
stay was directly related to the CRP levels as found by Bhat-
tacharya et al. [26] in their prospective cohort study on 30
patients >18 years old who required mechanical ventilation
and in Lobo et al. [27] on their 14 prospective cohort study
on 313 patients admitted to the ICU during the 4-month study
period. Elevation in serum CRP may be a mechanism to con-
trol acute inﬂammation by down-regulating some neutrophil
functions. Serum from high-risk and ARDS patients has sig-
niﬁcantly less neutrophil chemotactic activity than serum from
normal subjects [24].
960 T. Zaytoun et al.The effect of renal function as reﬂected by serum urea and
serum creatinine levels in both studied groups could be one of
the factors contributing to failure of weaning in the failed
group as decreased renal function is accompanied by acid–base
disturbances and volume status and altered immunity which
can increase the respiratory muscle load and negatively affect
lung compliance depression and in homeostasis of and that
can adversely affect respiratory function in addition the
depression of the mental state of these highly complicated
patients [28,29].
In agreement with this ﬁnding, it has been shown that in neu-
tropenic cancer patients, acute kidney injury (AKI) and acute
respiratory failure were the strongest predictors of mortality
[30]. And a recent study in ventilated cancer patients showed
that the severity of multiple organ failure, which includes
AKI, was among the main predictors of mortality [31].
As regards the scores used in the present work, APACHE
II score was applied to ensure adequate assessment of
condition of the included patients, the score was described
in 1985 and it was the most frequently used intensive care
severity of illness scoring system. It uses age, chronic health
evaluation, and 12 physiologic variables to predict hospital
mortality. The 12 physiologic variables are deﬁned as the
most abnormal values during the ﬁrst 24 h after ICU
admission. The main value of APACHE II score is to assess
severity of illness and to a lesser extent it could predict
mortality [32].
In the present work, the calculated APACHE II score was
signiﬁcantly higher in the failed group on admission, indicating
more severity of illness in this group.
The present work showed that Chromogranin A (CgA)
level was signiﬁcantly higher in the failed group throughout
the observation period as the CgA level was higher on admis-
sion in the ﬁrst group with a mean level of 1922.21 ±
1800.86 ng/ml compared to mean level of 224.87 ± 177.90
ng/ml and the same trend of CgA level occurred after 24 h
and after 72 h as the mean CgA level after 24 was
2240.16 ± 1927.84 ng/ml in the failed group compared to
mean level of 234.17 ± 165.81 ng/ml in the success group
and after 72 h the mean level was 2168.6 ± 1851.16 ng/ml in
the failed group in comparison to mean level of 256.70 ±
163.70 ng/ml in the success group and all were associated with
a statistically signiﬁcant difference between both groups
(p= 0.000). The response to critical illness as regulated by
the nervous, endocrine, hemodynamic and metabolic processes
is characterized by marked release of catecholamines which
correlates with the clinical outcome [33]. Chromogranin A
(CgA) is a neuroendocrine marker of sympathetic stress, has
been shown to be related to the stress load of the critical illness
[7,9]. Additionally, the endocrine system is an intimate contrib-
utor to an intact inﬂammatory response to stress and is crucial
for the host defense against infection [34]. Hypothalamic
hormones, including corticotropin-releasing hormone, vaso-
pressin, and inﬂammatory cytokines, such as IL-1, IL-6, and
TNF-a, have been identiﬁed as important modulators of
hypothalamic–pituitary–adrenal axis function [31]. This is vital
in preventing an uncontrolled inﬂammatory response to cyto-
kines that would have detrimental effects [35]. The adrenal
hormone epinephrine, the catecholamines of the sympathetic
nervous system, and most recently the cholinergic anti-inﬂam-
matory response have all been identiﬁed as important regula-
tors of innate immunity [36]. The sequelae of an unbalancedsystemic inﬂammatory reaction include increasingly destruc-
tive immunologic dissonance, resulting in shock, multiple-
organ dysfunction, and death [33].
Respiratory dysfunction is common in patients with SIRS
or sepsis and manifests as tachypnea, hypoxemia, and respira-
tory alkalosis. About 35% of patients with sepsis develop mild
to moderate acute lung injury (ALI), and up to one fourth
develop acute respiratory distress syndrome (ARDS) [37].Conclusions
Mechanical ventilation is an important tool in critical care
management of severe sepias and septic shock, and weaning
from it is an important challenge, chromogranin A is a marker
of catecholamine load released in response to critical illness
and was found to be a signiﬁcant marker that can be added
to the clinical and ventilatory predictors which can be used
to assess readiness for weaning in critically ill septic patients.Conﬂict of interest
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